Rating Scales

AIMS Tardive Dyskinesia Scale: Exam and TD Screen

Score the Abnormal Involuntary Movement Scale with body-area subtotals, the Schooler–Kane tardive dyskinesia screen, and a copyable exam report.

Open the AIMS

Runs free in your browser. Scores are calculated on your device and not sent to a server.

What it measures

The Abnormal Involuntary Movement Scale (AIMS) is a clinician-rated examination for detecting and monitoring tardive dyskinesia and other abnormal involuntary movements. The tool includes the standard 12-step examination procedure, with activation maneuvers such as finger tapping, arms extended, and walking, so the exam can be run in the same order each time.

Items and scoring

Items 1–7 rate movements from 0 (none) to 4 (severe) in seven areas, grouped into three subtotals:

GroupItemsRange
Facial and oral (facial expression, lips, jaw, tongue)1–40–16
Extremities (upper, lower)5–60–8
Trunk (neck, shoulders, hips)70–4
Total movement score1–70–28

Items 8–10 are global judgments (overall severity, incapacitation, and the patient's awareness and distress), and items 11–12 record dental status. These are reported but not added to the total.

Interpreting the result

The tardive dyskinesia screen uses the Schooler–Kane criterion: positive when two or more areas (items 1–7) are rated 2 (mild) or higher, or one area is rated 3 (moderate) or higher. Global item 8 is reported but does not make the screen positive by itself. The AIMS has no validated total-score severity bands. The tool shows the total in descriptive ranges (1–7, 8–14, 15–21, 22–28) only after items 1–7 are all rated, and directs severity judgments to the screen and item 8. A positive screen should prompt review of risk factors, length of antipsychotic exposure, and age, and other movement disorders should be ruled out.

What the report includes

The copyable report lists the date, each item rating, the three subtotals, the total, the screen result with the criterion used, any items rated 2 or higher, the global and dental items, and the scoring notes. The scale's reference is Guy's ECDEU Assessment Manual (1976). Unrated items count as 0, so complete the full examination before interpreting.

About PsychoPharmRef

PsychoPharmRef is a free clinical psychopharmacology reference built by Jerad Shoemaker, MD for psychiatrists, residents, and medical students. All tools are evidence-based and designed for point-of-care clinical decision support.

  • 101 psychiatric medications with receptor binding, P450, dosing, and monitoring data
  • 65 interactive clinical tools, rating scales, and therapy-course modules
  • Receptor binding profiles with bar chart, heatmap, and treemap views
  • PK curve comparison, P450 interaction checking, and a QTc calculator with Tisdale risk scoring
  • Medication taper and cross-taper planners
  • 124 evidence-based clinical chapters

PsychoPharmRef Clinical Reference | A resource for medical professionals | Page updated October 23, 2026

This tool is intended for educational purposes for healthcare professionals. Clinical decision-making should incorporate individual patient assessment and current guidelines.

PsychoPharmRef Newsletter

Stay current with AI-assisted reviews of new psychiatric research, FDA approvals, and guideline updates.